qwertyuiopasdfghjklzxcvbnmqwerty uiopasdfghjklzxcvbnmqwertyuiopasd fghjklzxcvbnmqwertyuiopasdfghjklzx cvbnmqwertyuiopasdfghjklzxcvbnmq wertyuiopasdfghjklzxcvbnmqwertyui opasdfghjklzxcvbnmqwertyuiopasdfg hjklzxcvbnmqwertyuiopasdfghjklzxc vbnmqwertyuiopasdfghjklzxcvbnmq wertyuiopasdfghjklzxcvbnmqwertyui opasdfghjklzxcvbnmqwertyuiopasdfg NIFTY OUTLOOK hjklzxcvbnmqwertyuiopasdfghjklzxc REPORT vbnmqwertyuiopasdfghjklzxcvbnmq 28 June 2017 wertyuiopasdfghjklzxcvbnmqwertyui opasdfghjklzxcvbnmqwertyuiopasdfg hjklzxcvbnmrtyuiopasdfghjklzxcvbn mqwertyuiopasdfghjklzxcvbnmqwert yuiopasdfghjklzxcvbnmqwertyuiopas th
28th June 2017
NIFTY
NIFTY SPOT : PIVOT : 9536
R1:9593 S1:9490
R2:9673 S2:9455
R3:9700 S3:9410
NIFTY DAILY CHART NIFTY OUTLOOK Nifty is likely to open in a negative note. Momentum indicators like RSI are indicating towards a signal of reversal. Yesterday nifty was able to defend the level of 9500.Intraday traders are advised to adopt buy on dips strategy for today’s trading session. Positional traders are advised to keep their stop loss at 9450 for longs while for contra positions it should be placed at 9600. Strategy: buy nifty around 9475 t1 9500 t2 9525 sl 9430
Name FTSE 100 (Jun 27) CAC 40 (Jun 27)
Current Value
Change
% Chg
Open
High
Low
7,434.36
-12.44
-0.17
7,446.80
7,451.68
7,411.36
5,258.58
-37.17
-0.71
5,282.87
5,284.96
5,237.67
DAX (Jun 27) Nikkei 225 (Jun 28) Straits Times (Jun 28) Hang Seng (Jun 28) Taiwan Weighted (Jun 28) SGX Nifty (Jun 28)
12,671.02
-99.81
-0.79
12,728.50
12,751.20
12,644.95
20,153.70
-71.39
-0.35
20,149.20
20,224.30
20,144.88
3,204.83
-14.7
-0.46
3,217.50
3,221.23
3,203.75
25,725.50
-114.49
-0.45
25,735.21
25,821.36
25,625.71
10,405.25
-106.81
-1.03
10,459.17
10,459.17
10,384.86
9,501.50
-15
-0.16
9,512.00
9,514.50
9,479.00
WWW.EQUITYRESEARCHLAB.COM
28th June 2017
CORPORATE NEWS
US FDA -Announces 2 new steps to encourage generic drug development & access -Publishes a list of off-patent branded drugs without approved generics -Implements policy to expedite review of generic drug applications -Policy to review generic drug applications where competition is limited -Sangam Advisors has been awarded letter of award by Maharashtra State Power Generation Company for design, manufacturing and commissioning 2MV grid interactive solar plant -AU Small Finance Bank opens for subscription today, price band Rs 355-358/share -Country Club board approves to sell off assets to reduce debt, current debt at Rs 407 crore (market capitalisation Rs 27 crore) -DSP Blackrock buys 4.7 lakh shares of Arrow Greentech at a price of Rs 530 -ONGC gets green nod to explore shale gas in KG basin -Coal India receives high re-auction realisations in June: ET -Liberty House in talks to buy in ABG Shipyard: BS -Cadila Healthcare aims to double US business in 3 years: BS -Raymond to invest Rs 1,400 crore in its Maharashtra plant -Ashok Leyland to focus on commercial vehicle business: BS -Natural gas may be included in GST, which may benefit ONGC -Blackstone exits Jagran Prakashan: Mint -Godrej Consumer Products eyes acquisition in skincare segment: Mint -Indiabulls Real Estate acquires entire minority stake of 10.08 percent in unit Indiabulls Infraestate for Rs 358 crore -Federal Bank QIP closes on Tuesday; QIP issue price at Rs 116 per share -Anti-Trust Body okays Red Bloom's buy of 9 percent stake in ICICI Lombard: Cogencis -Capital First raises Rs 50 crore via issue of non-convertible debentures on a private placement basis -LIC cuts stake in Hero Motocorp by 2.03 percent to 5.14 percent -SpiceJet launches fares starting Rs 699 for travel between July 14 -March 24.
WWW.EQUITYRESEARCHLAB.COM
28th June 2017
ERL RESEARCH TEAM Member Name
Designation
E-mail ID
Mr. Tuhinanshu Jain Mr. Manish Bimal
Research Head Sr. Research Analyst
Tuhinanshu.jain@equityresearchlab.co.in Manish.bimal@equityresearchlab.co.in
DISCLAIMER The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Investment in Stocks has its own risks. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. We, however, do not vouch for the accuracy or the completeness thereof. This material is for personal information and we are not responsible for any loss incurred based upon it & takes no responsibility whatsoever for any financial profit s or loss which may arise from the recommendations above. The stock price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Equity Research Lab does not purport to be an invitation or an offer to buy or sell any financial instrument. Analyst or any person related to Equity Research Lab might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Any surfing and reading of the information is the acceptance of this disclaimer. Our Clients (Paid or Unpaid), any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken. Any surfing and reading of the information is the acceptance of this disclaimer. ALL RIGHTS RESERVED.
WWW.EQUITYRESEARCHLAB.COM